These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids. Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650 [No Abstract] [Full Text] [Related]
3. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus. Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648 [No Abstract] [Full Text] [Related]
4. Experience with basiliximab in pediatric liver graft recipients. Ganschow R; Lyons M; Grabhorn E; Venzke A; Broering DC; Rogiers X; Hellwege HH; Burdelski M Transplant Proc; 2001; 33(7-8):3606-7. PubMed ID: 11750532 [No Abstract] [Full Text] [Related]
5. Basiliximab in the therapy of acute rejection after organ transplantation. Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567 [No Abstract] [Full Text] [Related]
6. First experience with basiliximab in pediatric liver graft recipients. Ganschow R; Broering DC; Stuerenburg I; Rogiers X; Hellwege HH; Burdelski M Pediatr Transplant; 2001 Oct; 5(5):353-8. PubMed ID: 11560755 [TBL] [Abstract][Full Text] [Related]
7. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926 [TBL] [Abstract][Full Text] [Related]
8. Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Sudan DL; Chinnakotla S; Horslen S; Iyer K; Fox I; Shaw B; Langnas AN Transplant Proc; 2002 May; 34(3):940-1. PubMed ID: 12034250 [No Abstract] [Full Text] [Related]
10. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months. Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR Transplant Proc; 2006 Dec; 38(10):3633-5. PubMed ID: 17175352 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Ganschow R; Grabhorn E; Schulz A; Von Hugo A; Rogiers X; Burdelski M Pediatr Transplant; 2005 Dec; 9(6):741-5. PubMed ID: 16269045 [TBL] [Abstract][Full Text] [Related]
12. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children. Gras JM; Gerkens S; Beguin C; Janssen M; Smets F; Otte JB; Sokal E; Reding R Liver Transpl; 2008 Apr; 14(4):469-77. PubMed ID: 18383091 [TBL] [Abstract][Full Text] [Related]
13. Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation. Boggi U; Vistoli F; Coppelli A; Marchetti P; Rizzo G; Mosca F Transplant Proc; 2001; 33(7-8):3201-2. PubMed ID: 11750373 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406 [TBL] [Abstract][Full Text] [Related]
15. The use of anti-interleukin-2 receptor antibodies in pediatric liver transplantation. Kelly DA Pediatr Transplant; 2001 Dec; 5(6):386-9. PubMed ID: 11737761 [No Abstract] [Full Text] [Related]
16. Acute rejection after liver transplantation despite intragraft coating by interleukin-2 receptor-alpha with basiliximab. Kwekkeboom J; Maas M; Rietveld JH; Zondervan PE; Bouma GJ; Tilanus HW; Metselaar HJ Transplant Proc; 2001; 33(1-2):1071-3. PubMed ID: 11267195 [No Abstract] [Full Text] [Related]
17. Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. Varo E; Lopez A; Castroagudin JF; Delgado M; Conde R; Ferrer E; Otero E; Tomé S; Bustamante M; Rivero C; Martinez J; Mariño A Transplant Proc; 2002 Aug; 34(5):1533-4. PubMed ID: 12176471 [No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab. Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617 [TBL] [Abstract][Full Text] [Related]